Analysis of Patent and Regulatory Exclusivity for Novel Agents in China and the United States: A Cohort Study of Drugs Approved Between 2018 and 2021

中国 激励 商标 知识产权 医学 业务 药理学 法学 政治学 经济 微观经济学
作者
Xingxian Luo,Lina Yang,Xin Du,Jingshu Yang,Qian Feng,Yang Yue
出处
期刊:Clinical Pharmacology & Therapeutics [Wiley]
卷期号:112 (2): 335-343 被引量:15
标识
DOI:10.1002/cpt.2625
摘要

Patent and regulatory exclusivity shall constitute incentives for pharmaceutical companies to develop new drugs. This study aims to investigate the differences in the patent term extension (PTE) and regulatory exclusivity between China and the United States, and to evaluate their potential impact on the market exclusivity period of novel drugs. Small-molecule novel drugs with their first indication approved in China and the United States between 2018 and 2021 were evaluated regarding their PTE and regulatory exclusivity. The PTE length of the China-approved drugs was calculated by simulation, whereas that of the US-approved drugs was extracted from the United States Patent and Trademark Office. Thirty-two and 107 novel drugs approved in China and the United States, respectively, were included in the study. The PTE length of the US-approved drugs calculated by the China-PTE method was significantly longer than that calculated by the US-PTE method. Patent extensions should be granted for 91% of new drugs in China and 82% in the United States. The simulated median PTE length of novel drugs approved in China was significantly higher than that of the United States (5.0 vs. 2.9 years, P < 0.05). It can be expected that the implementation of the PTE policy in China would significantly extend the period of market exclusivity for novel drugs similar to that of the United States. China should fully evaluate the potential impact of the PTE policy on the market exclusivity of novel drugs and provide better incentives to the development of novel drugs in addressing unmet clinical needs when developing its regulatory exclusivity policy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xueee完成签到,获得积分10
刚刚
刚刚
Kiyo完成签到 ,获得积分10
2秒前
huahua完成签到,获得积分10
2秒前
3秒前
3秒前
3秒前
4秒前
5秒前
ee完成签到,获得积分10
5秒前
令狐大侠发布了新的文献求助10
5秒前
ss发布了新的文献求助10
5秒前
向往完成签到 ,获得积分10
6秒前
打打的应助被嘿嘿采纳,获得10
6秒前
称心文博完成签到,获得积分20
6秒前
科研小白发布了新的文献求助10
6秒前
l74475397完成签到,获得积分10
7秒前
7秒前
8秒前
8秒前
li完成签到,获得积分10
8秒前
ubless607的应助被CC采纳,获得10
9秒前
电灯胆完成签到,获得积分10
10秒前
红与黑完成签到,获得积分10
10秒前
10秒前
suiyi发布了新的文献求助10
10秒前
木槿花开完成签到 ,获得积分10
10秒前
grace完成签到 ,获得积分0
11秒前
犹豫耳机完成签到,获得积分10
11秒前
从容襄完成签到,获得积分10
11秒前
mmm发布了新的文献求助10
12秒前
可爱的函函的应助被开心德地采纳,获得10
12秒前
13秒前
然大宝发布了新的文献求助10
14秒前
汉堡包的应助被星空采纳,获得10
14秒前
AndyHC完成签到,获得积分10
14秒前
武陵济世完成签到,获得积分10
14秒前
神猪无敌完成签到 ,获得积分10
14秒前
李健的小迷弟的应助被ss采纳,获得10
15秒前
Effyyy完成签到 ,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185632
求助须知:如何正确求助?哪些是违规求助? 9574360
关于积分的说明 21835672
捐赠科研通 7783457
什么是DOI,文献DOI怎么找? 3434643
关于科研通互助平台的介绍 2558998
邀请新用户注册赠送积分活动 2481403